To access this element change to forms mode OFF
Grant Award View - GA59384
Validating glycosylation as a therapeutic target to prevent malaria...
GA ID:
GA59384
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
1-Aug-2019
Publish Date:
17-Oct-2019
Category:
Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2024
Value (AUD):
$2,510,666.23
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 19/20 1.1 Health and Medical Research
Grant Program:
Investigator
Grant Activity:
Validating glycosylation as a therapeutic target to prevent malaria transmission
Purpose:
The parasites that cause malaria have unique proteins on their surface that are essential for infection of humans and mosquitoes. These proteins are useful for making vaccines to train the immune system to recognize and block malaria infection. Our latest research has shown that these proteins are modified with sugars that enhance parasite virulence. We are studying these modifications more closely to facilitate the development of improved malaria vaccines.
GO ID:
GO Title:
Investigator Grants 2019
InternalReferenceId:
GNT1176955
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA